Showing posts with label depression. Show all posts
Showing posts with label depression. Show all posts

Wednesday, August 14, 2013

Help raise awareness of Post-Natal Depression this Friday with @OneMillionMums

According to an NHS report in 2011, post-natal depression affects an estimated 10-15% of new mothers. A shocking statistic you'll no doubt agree, it's also no wonder a whole host of celebrities have come out in support of the Samantha Abbott Trust - a charity aimed at helping mums who suffer from PND.

Founded by Simon Abbot, the charitable trust was set up in memory of Simon's sister Samantha, who tragically committed suicide in 2009, shortly after giving birth and developing post-natal depression.

In aid of the cause, Russell Brand - along with stars such as Beverley Knight and Stacey Solomon - have joined forces to support the trust's plan to break the Twitter Guinness World Record of 'Fastest 1 Million Followers'. Currently held by Charlie Sheen, the record is 25 hours and 17 minutes, and we're asking you to pledge your support.

So, how can you get involved? Well, it's simple. At 10.00am on 26th April (this Friday - put it in the diary) the @OneMillionMums Twitter profile will go live and all you have to do is follow the account to help  smash the world record.

Speaking about the trust's record-breaking attempt, Abbott said: "Many mums suffer in silence as they are too afraid to say anything in case people think they are a bad mum or that their baby may be taken away... However, with the support of so many celebrities, and celebrity mums speaking up, we hope that other mums will be more open and support each other."

For more information see Facebook and follow @OneMillionMums on Twitter, this Friday.

« Back to more Life, Love & Sex

View the original article here

Saturday, August 10, 2013

Infection, autoimmune disease linked to depression

Patrick J. Skerrett
Posted June 17, 2013, 5:47 am Bacteria in the bloodstream

Depression, bipolar disorder, and other mental health problems arise when something goes wrong with brain function. What causes that malfunction is an open question. In some people, a serious infection or autoimmune disease could be the trigger.

A report published online in JAMA Psychiatry explores this hypothesis. Researchers turned to comprehensive Danish databases that include all Danes born in the country, each identified by a unique registration number. One of the databases stores health-related information, including records of hospitalizations. Among Danes born between 1945 and 1995, almost 92,000 had a mood disorder. Of these, 36,000 had suffered a severe infection or developed an autoimmune disease (such as type 1 diabetes, celiac disease, lupus, and the like) at some point before being diagnosed with the mood disorder.

People who had been treated for a severe infection were 62% more likely to have developed a mood disorder than those who never had one. An autoimmune disease increased the risk by 45%. Multiple infections or the combination of severe infection and an autoimmune disease boosted the odds of developing depression, bipolar disorder, or another mood disorder even further.

The researchers estimated that in the Danish population, severe infection and autoimmune disease account for 12% of mood disorders.

“A link between infection and depression and mood disorders is intriguing,” says Dr. Michael C. Miller, assistant professor of psychiatry at Harvard Medical School and a member of JAMA Psychiatry’s editorial board. “But it’s important to keep in mind that both infections and mood disorders are very common, making it difficult to tease out what causes what.”

He ticks off three possible explanations for the results:

Severe infection and autoimmune disease may cause mood disorders.Mood disorders may create a susceptibility to infection or autoimmune disease.Mood disorders, severe infection, and autoimmune disorders may share common triggers.

The Danish study isn’t the first to explore links between infection or autoimmune diseases and depression. Much of the evidence supports a connection.

Depression isn’t the only mental health issue that may be related to infections and autoimmune condition. Writing last year in the Harvard Health blog, Dr. Jeff Szymanski described how some children with strep throat suddenly develop obsessive-compulsive disorder. It’s one manifestation of pediatric acute-onset neuropsychiatric syndrome. Quick treatment with antibiotics can reverse the problem.

How might an infection or autoimmune disorder lead to a mood or other mental health disorder? Infection causes localized and body-wide inflammation. Inflammation generates substances called cytokines that have been shown to change how brain cells communicate. In autoimmune diseases, the body’s defense system attacks healthy tissues rather than threatening invaders. It’s possible that in some cases the wayward immune reaction could target brain cells and other nerve cells throughout the body.

The connection between infection, autoimmune disease, inflammation, and mood disorders has prompted some researchers to wonder “Can we vaccinate against depression?” The short answer, at least for now, is “no.”

But there are things you can do. “Healthy living has all sorts of benefits,” says Dr. Miller. It can help you fight infection, reduce inflammation, ease stress, and make you feel better day to day, all of which work against the development of a mood disorder.”

Share

View the original article here

Saturday, July 20, 2013

College Sports Could Raise Players' Risk for Depression, Study Finds

Compared with former college athletes, those still in school had doubled odds, possibly due to stress, researchers sayCompared with former college athletes, those

By Robert Preidt

HealthDay Reporter

FRIDAY, April 5 (HealthDay News) -- Current college athletes are twice as likely to be depressed as former athletes, researchers have found.

The findings suggest the need for further research to learn more about depression among college athletes, the Georgetown University investigators said.

For the study, they examined questionnaires completed by 117 current and 163 former college athletes who had participated in Division I NCAA-sponsored sports. The current athletes played in 10 different sports and the former athletes had played in 15 different sports.

Nearly 17 percent of current athletes had questionnaire scores consistent with depression, compared with 8 percent of former athletes, according to the study published online recently in the journal Sports Health.

"We expected to see a significant increase in depression once athletes graduated, but by comparison it appears the stress of intercollegiate athletics may be more significant than we and others anticipated," senior investigator Dr. Daniel Merenstein, an associate professor of family medicine and human science at Georgetown University Medical Center, said in a university news release.

These stressors include things such as overtraining, injury, pressure to perform, lack of free time, or trying to juggle athletics and schoolwork.

"College in general is a potentially stressful time for many students. The additional stress of playing high-level sports appears to add to that stress," Merenstein said.

He advised parents, friends and coaches to pay attention to changes in behavior, weight and sleep of college athletes, and of all students.


View the original article here

Tuesday, July 16, 2013

College Sports Could Raise Players' Risk for Depression, Study Finds

Compared with former college athletes, those still in school had doubled odds, possibly due to stress, researchers sayCompared with former college athletes, those

By Robert Preidt

HealthDay Reporter

FRIDAY, April 5 (HealthDay News) -- Current college athletes are twice as likely to be depressed as former athletes, researchers have found.

The findings suggest the need for further research to learn more about depression among college athletes, the Georgetown University investigators said.

For the study, they examined questionnaires completed by 117 current and 163 former college athletes who had participated in Division I NCAA-sponsored sports. The current athletes played in 10 different sports and the former athletes had played in 15 different sports.

Nearly 17 percent of current athletes had questionnaire scores consistent with depression, compared with 8 percent of former athletes, according to the study published online recently in the journal Sports Health.

"We expected to see a significant increase in depression once athletes graduated, but by comparison it appears the stress of intercollegiate athletics may be more significant than we and others anticipated," senior investigator Dr. Daniel Merenstein, an associate professor of family medicine and human science at Georgetown University Medical Center, said in a university news release.

These stressors include things such as overtraining, injury, pressure to perform, lack of free time, or trying to juggle athletics and schoolwork.

"College in general is a potentially stressful time for many students. The additional stress of playing high-level sports appears to add to that stress," Merenstein said.

He advised parents, friends and coaches to pay attention to changes in behavior, weight and sleep of college athletes, and of all students.


View the original article here

Sunday, July 14, 2013

College Sports Could Raise Players' Risk for Depression, Study Finds

Title: College Sports Could Raise Players' Risk for Depression, Study Finds
Category: Health News
Created: 4/5/2013 10:35:00 AM
Last Editorial Review: 4/5/2013 12:00:00 AM

View the original article here

Tuesday, July 9, 2013

Another Danger of Depression?

Title: Another Danger of Depression?
Category: Health News
Created: 3/29/2013 12:35:00 PM
Last Editorial Review: 4/1/2013 12:00:00 AM

View the original article here

Monday, June 10, 2013

Anxiety, Depression May Triple Risk of Death for Heart Patients: Study

Researcher recommends stress-reducing measuresResearcher recommends stress-reducing measures.

By Steven Reinberg

HealthDay Reporter

TUESDAY, March 19 (HealthDay News) -- Anxiety and depression coupled with heart disease triples the risk of death compared to cardiac trouble alone, researchers have found.

Among heart patients, anxiety can double the risk of dying from any cause, the study authors noted, and depression further raises those odds.

"Patients with heart disease who experience high anxiety during the stressors of everyday life may benefit from treatments designed to reduce anxiety, such as medications targeting anxiety or stress management," said lead researcher Lana Watkins, an associate professor of psychiatry and behavioral sciences at Duke University Medical Center in Durham, N.C.

"Benefits from stress-reducing interventions would potentially be greatest in patients where anxiety is found in combination with depression," she added.

Previous studies have shown that depression is about three times more common in heart attack patients than in others. But few studies have looked at anxiety's effect or the combination of the two on heart disease patients.

One expert, Dr. Gregg Fonarow, a spokesman for the American Heart Association and a professor of cardiology at the University of California, Los Angeles, agreed anxiety and depression are most lethal when they co-exist.

"Depression and anxiety have both been individually associated with a higher risk of developing cardiovascular disease, and in patients with cardiovascular disease [they are] associated with higher risk of recurrent cardiovascular events and death," Fonarow said.

This new study finds that anxiety, particularly when accompanying depression, independently increased risk of dying, he added.

The report was published March 19 in the Journal of the American Heart Association.

Anxiety is a common mental health problem, with about one-third of U.S. adults experiencing an anxiety disorder in their lifetime, the researchers noted. And heart disease is the leading cause of death in the United States.

For the study, more than 900 heart disease patients, average age 62, answered a questionnaire measuring their level of anxiety and depression right before or just after coronary angiography, which can be a stressful cardiac procedure. The test uses special X-rays and dyes to view the coronary arteries.

The investigators found that 90 patients had anxiety, 65 had depression and 99 suffered from both.

Of the 133 patients who died over the three years of follow-up, 55 suffered from anxiety, depression or both, the researchers reported. Most of these deaths (93) were related to heart disease, they noted.

Patients who are highly anxious during a stressful life experience, such as a cardiac hospitalization, are at an increased risk of dying, and this risk is independent of the severity of their heart disease and also of depression, Watkins said.

According to the researchers, anxiety can increase inflammation and blood pressure. Fatigue or feelings of worthlessness associated with depression may cause people to ignore their treatment for heart disease.


View the original article here

Sunday, June 9, 2013

Talk Therapy Can Ease Depression, But No Single Type Deemed 'Best'

Experts say choice depends on individual patient, treatment availabilityExperts say choice depends on individual patient,

By Amy Norton

HealthDay Reporter

TUESDAY, May 28 (HealthDay News) -- Various forms of "talk therapy" can help people with depression, but no single type stands out as better than the rest, according to a new analysis.

Experts said the results confirm what is generally thought: Psychotherapy can help lift depression, and there is no one form that is best for everyone.

Instead, a person's therapy choice may come down to the nature of the depression, and practical matters -- like finding a therapist you're comfortable with, and being able to pay.

In the study, published online May 28 in PLoS Medicine, Swiss researchers from the University of Bern analyzed nearly 200 clinical trials testing seven different types of psychotherapy for major depression. Overall, they found that all of the therapies were better than no treatment. The typical effect was "moderate to large," they say -- which means that the average patient who received the therapy was doing better than half of the patients in the untreated, comparison group.

"This study is reassuring, because it shows all of these therapies can work," said Dr. Bryan Bruno, acting chair of psychiatry at Lenox Hill Hospital, in New York City, who was not involved with the analysis. "I'd encourage people to get educated about the different types of therapy that are out there."

Most of the studies in the review (70 percent) tested cognitive-behavioral therapy -- which aims to change the dysfunctional thinking and behavior that feed a person's depression. In the United States, it's the most widely available talk therapy for depression.

Another approach is known as interpersonal therapy, which focuses on improving a patient's relationships and social skills.

Interpersonal therapy is well-studied, but it's harder to find than cognitive behavioral therapy, said Steven Hollon, a professor of psychology at Vanderbilt University in Nashville, Tenn., who was not involved in the review.

Both cognitive behavioral and interpersonal therapies are attractive, in part, because they are fairly short-term -- typically lasting for 10 to 20 sessions over a few months.

Some other therapies, like an approach known as supportive counseling, are longer term, Bruno noted. So your ability to pay may be an obstacle, even if the therapy is available to you.

"Most insurers do not dictate the type of psychotherapy they'll pay for," Bruno said. "But they may dictate the number of sessions."

The nature of depression varies widely from person to person, so ideally psychotherapy would be individualized. Bruno said that a person who has suffered a trauma, for example, might benefit from short-term "psychodynamic therapy" -- where the therapist tries to help you figure out how past experiences, from childhood onward, may be affecting your mental health now.

"Or sometimes a therapist will use a combination of therapies, depending on what seems best for the patient," Bruno said.


View the original article here

Thursday, June 6, 2013

Depression May Boost Stroke Risk in Middle-Aged Women, Too

Although risk is still low, Australian study found it nearly doubled for depressed women in their 40s and 50sThose around them don't take their attacks

By Steven Reinberg

HealthDay Reporter

THURSDAY, May 16 (HealthDay News) -- Women in their 40s and 50s who suffer from depression are almost twice as likely to have a stroke as women who aren't depressed, according to a large, long-running Australian study.

This is not the first study to link depression with an increased risk for stroke, in both men and women. Exactly how depression is associated with stroke is unclear, as is whether treating it reduces the risk, experts say.

"Although the absolute risk of stroke is low in mid-aged women, depression does appear to have a large adverse effect on stroke risk in this age group," said lead researcher Caroline Jackson, an epidemiologist in the School of Population Health at the University of Queensland.

"Our findings, however, suggest that depression may be a stronger risk factor for stroke in mid-aged women than was previously thought," she said.

Despite the growing body of evidence on depression and risk of stroke, depression is generally not included in guidelines for primary stroke prevention, which appears to be an important omission that should be addressed, Jackson noted.

The report was published May 16 in the journal Stroke.

One expert said this latest finding adds to the growing pile of evidence on the link.

"This large study among Australian women adds further evidence supporting the association between depression and stroke risk," said Dr. Ralph Sacco, chairman of neurology at the University of Miami Miller School of Medicine.

Other studies have also demonstrated the effects of depression on stroke risk, he added. "Although we are not clear about the mechanisms, depression is frequent and needs to be more readily recognized and appropriately treated," Sacco said.

To see how much depression influenced the risk of stroke, Jackson and her colleague Gita Mishra, a professor of life course epidemiology at the University of Queensland, collected data on more than 10,000 women aged 47 to 52 who took part in the Australian Longitudinal Study on Women's Health.

Women in the survey answered questions about both physical and mental health every three years from 1998 to 2010.

Among these women, about 24 percent said they suffered from depression. Over the study period 177 women had a stroke for the first time.

Analysis by Jackson and Mishra found depressed women were 2.4 times more likely to have a stroke than women who weren't depressed.

After eliminating some of the other factors that increase the risk of stroke, depressed women still were 1.9 times more likely to have a stroke, compared to women who were not depressed, they found.

Risk factors included: age; socioeconomic status; lifestyle habits such as smoking, alcohol and physical activity; and high blood pressure, heart disease, being overweight and diabetes.


View the original article here

Wednesday, May 29, 2013

Genes May Boost Woman's Risk of Postpartum Depression

Test found specific changes to two genes predicted problem with 85 percent accuracy

By Amy Norton

HealthDay Reporter

TUESDAY, May 21 (HealthDay News) -- Pregnant women with specific alterations in two genes may be at increased risk of suffering depression after giving birth, a small new study suggests.

The researchers hope they can use the findings to develop a blood test that could help spot pregnant women who are vulnerable to postpartum depression, which affects around 15 percent of new mothers.

Their study, reported in the May 21 issue of the journal Molecular Psychiatry, uncovered specific chemical changes in two genes that predicted which women would develop postpartum depression with 85 percent accuracy.

Little is known about the genes, called TTC9B and HP1BP3, but they are somehow involved in activity in the brain's hippocampus, which regulates mood. Based on animal research, both genes seem to be "reactive to estrogen," said Zachary Kaminsky, a researcher at Johns Hopkins University School of Medicine in Baltimore who worked on the study.

The findings offer clues as to what makes some women susceptible to postpartum depression. But there is still a lot of work to be done before a screening test becomes available, according to an expert not involved in the research.

"This is a first step, but I think we're pretty far off from having a blood test," said Dr. Kimberly Yonkers, a professor of psychiatry and obstetrics and gynecology at Yale School of Medicine in New Haven, Conn.

She said the study was small -- involving only 51 women, about a dozen of whom developed depression within a month of giving birth -- so the results need to be validated in larger studies.

But beyond that, Yonkers said, there's the larger, "dicey" issue of how much benefit there would be from telling pregnant women their genes put them at heightened risk of postpartum depression.

"You may unnecessarily worry some women," Yonkers said.

"Information is power," Kaminsky said, and for some women, knowing they are at risk of postpartum depression can offer a chance to minimize that risk: Their partner, family or friends could be especially attentive and step in to ease some of the stress of being a new mom, for example.

Kaminsky acknowledged that if a blood test result actually caused distress for an expectant mom, it would not be good. But, he said, having a blood test as an option for women who want an idea of their risk could be valuable.

Kaminsky and two of his co-researchers have filed for a patent on testing for the genetic markers.

The findings are based on 51 pregnant women with a history of depression or bipolar disorder, which raises the risk of suffering depression during or after pregnancy. One group of 19 women had major depression during their pregnancies, and 12 continued to have symptoms in the first month after giving birth.


View the original article here

Sunday, May 26, 2013

Childhood Depression May Be Tied to Later Heart Risk: Study

For these kids, obesity, smoking and inactivity more likely in adolescence, preliminary research showsRotavirus infection causes severe

By Robert Preidt

HealthDay Reporter

FRIDAY, March 15 (HealthDay News) -- Teens who were depressed as children are more likely to be obese, to smoke and to be sedentary, a new study finds.

The findings suggest that depression during childhood can increase the risk of heart problems later in life, according to the researchers.

The study included more than 500 children who were followed from ages 9 to 16. There were three groups: those diagnosed with depression as children, their depression-free siblings and a control group of unrelated youngsters with no history of depression.

Twenty-two percent of the kids who were depressed at age 9 were obese at age 16, the study found. "Only 17 percent of their siblings were obese, and the obesity rate was 11 percent in the unrelated children who never had been depressed," study first author Robert Carney, a professor of psychiatry at Washington University School of Medicine in St. Louis, said in a university news release.

The researchers found similar patterns when they looked at smoking and physical activity.

"A third of those who were depressed as children had become daily smokers, compared to 13 percent of their nondepressed siblings and only 2.5 percent of the control group," Carney said.

Teens who had been depressed as children were the least physically active, their siblings were a bit more active and those in the control group were the most active, according to the study, which is scheduled for presentation Friday at the annual meeting of the American Psychosomatic Society in Miami. Although the study showed an association between childhood depression and obesity, smoking habits and inactivity later in life, it did not prove a cause-and-effect relationship.

These findings are cause for concern because "a number of recent studies have shown that when adolescents have these cardiac risk factors, they're much more likely to develop heart disease as adults and even to have a shorter lifespan," Carney said.

"Active smokers as adolescents are twice as likely to die by the age of 55 than nonsmokers, and we see similar risks with obesity, so finding this link between childhood depression and these risk factors suggests that we need to very closely monitor young people who have been depressed," he said.

Data and conclusions presented at meetings are typically considered preliminary until published in a peer-reviewed medical journal.


View the original article here

Having Both Migraines, Depression May Mean Smaller Brain

But it's unclear what the finding might mean for patientsStudy found more short-range connections, fewer

By Maureen Salamon

HealthDay Reporter

WEDNESDAY, May 22 (HealthDay News) -- Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely -- a smaller brain.

Already aware that people with migraines face double the risk of depression, scientists wanted to determine if having both conditions together affected total brain volume. The difference in size -- about 2 percent -- isn't alarming, study authors said, but needs further research to determine if the disparity causes any meaningful health effects.

"There are several potential explanations why those with both conditions have smaller brain volume," said study author Larus Gudmundsson, a research associate at the Uniformed Services University of the Health Sciences in Bethesda, Md. "There could be some genetic factor driving the whole thing. It could be related to pain mechanisms [in the brain]. It's also possible there are social and economic reasons."

The study is published in the May 22 online issue of the journal Neurology.

More than 36 million Americans -- about 12 percent of the population -- are estimated to suffer from migraine headaches, which can be debilitating, according to the U.S. National Library of Medicine. Meanwhile, major depression affects 15 million people, and Gudmundsson estimated that perhaps 3 percent to 4 percent of Americans suffer from both conditions.

Gudmundsson and his colleagues analyzed data from Iceland on about 4,300 older adults at two time points. At an average age of 51, participants were assessed for migraine headache incidence and about 25 years later were asked about their lifetime history of major depressive disorder. A full-brain MRI scan was taken at that later point to measure brain volume, when participants were between 66 and 96 years old.

Compared to those with no history of migraines or depression, those with both conditions had brain volumes about 2 percent smaller. There was no difference in the total brain volume when comparing people with only one of the conditions to those with neither condition.

Although the study found a connection between brain size and the combination of migraines and depression, it did not show a cause-and-effect relationship, as one expert noted.

"We certainly know that migraine sufferers tend to have smaller brains than non-migraine sufferers. But I'm not sure this study confirms that, apart from a neurodegenerative process, the two diseases act to do anything to increase the rate of [brain shrinkage] with aging," said Dr. Dara Jamieson, an associate professor of clinical neurology and director of the headache center at New York-Presbyterian/Weill Cornell Medical Center, in New York City.

"The people they were imaging [with MRI] were quite old -- 66 to 96 -- and you can expect brain atrophy in that group," added Jamieson, who was not involved with the study. "Maybe there's something to be said for these disorders accelerating brain atrophy ... but to take away that because of migraine and depression that your brain is smaller is unnecessarily glum."

Study author Gudmundsson, who's also a guest researcher at the U.S. National Institute on Aging, pointed out that those with migraines and depression may not suffer brain shrinkage since it's possible that their brains are smaller from birth.

"The clinical impact needs to be determined," he added. "We have to keep in mind that several studies have looked at migraine and cognition [thinking ability] and have not found a difference in cognition. That is reassuring."


View the original article here

Monday, May 20, 2013

Antipsychotic Meds Not That Helpful for Depression: Study

These drugs, meant for other conditions, come with side effects including weight gainMore than 600 prescription and over-the-counter

By Steven Reinberg

HealthDay Reporter

TUESDAY, March 12 (HealthDay News) -- For people who don't fully respond to antidepressants, adding commonly prescribed antipsychotic drugs appears to be only slightly effective and is linked to unwelcome side effects, a new study finds.

Drugs added to antidepressants (like Prozac, Paxil and Celexa) include the antipsychotic medications aripiprazole (Abilify), quetiapine (Seroquel), risperidone (Risperdal) and olanzapine/fluoxetine (Symbyax).

Antipsychotic drugs are traditionally used to treat conditions such as schizophrenia, bipolar disorder and obsessive-compulsive disorder -- not depression.

"The evidence supporting the use of antipsychotics in depression is marginal," said lead researcher Glen Spielmans, an associate professor in the department of psychology at Metropolitan State University in St. Paul, Minn.

Antipsychotic treatment of depression has become increasingly widespread but the underlying evidence base puts this practice into question, he said.

"Other options may be as effective, or more effective, and carry a lesser side-effect burden," Spielmans said. For instance, cognitive behavioral therapy has been shown to be effective for treatment-resistant depression, he said. Cognitive behavioral therapy is a treatment that helps patients try to change their thoughts, feelings and behaviors.

For one expert, these drugs also aren't a first choice for patients who don't respond fully to antidepressants.

"I have mixed results in terms of how effective they are," said Dr. Bryan Bruno, acting chair of psychiatry at Lenox Hill Hospital, in New York City.

"I treat a lot of patients who are on antidepressants and not responding well. Prescribing these drugs is not something I do often because of the costs and because of the side effects," said Bruno, who was not involved with the study.

Some of these drugs are pricey. For example, Abilify can cost more than $200 a month without insurance, according to the Everyday Health website. With insurance the cost varies by plan.

"I prefer using other strategies like adding other antidepressants, or using brain stimulation treatments, and psychotherapy," Bruno said.

For some patients, however, these antipsychotics can be helpful, including those with insomnia and those whose depression is coupled with a psychosis, he noted.

The report was published in the March issue of the online journal PLoS Medicine.

To gauge the effectiveness of these drugs, Spielmans' team pooled data from 14 studies that compared antipsychotic medications to an inactive placebo in patients for whom antidepressants weren't enough to relieve depression.

This process, called a meta-analysis, attempts to find common threads from different studies that reveal a pattern, which adds information beyond what one study finds.

The new analysis found these drugs offered only a small benefit in relieving symptoms of depression and little or no benefit in improving patients' quality of life or ability to function.

The drugs did, however, have some unwelcome side effects such as restlessness, sleepiness, weight gain and some abnormal lab test results such as increased cholesterol levels, the researchers reported.

Spielmans suggested that some of the trials they looked at may have tried to boost the perception of the effectiveness of the drug and downplay its side effects.

"Studies were sometimes designed in a biased manner that may have slanted the results," Spielmans said. "Data were sometimes reported in a way that likely made the drugs appear more effective than they actually were."

In addition, he said, the researchers found that some side effects were tucked away on the U.S. Food and Drug Administration's website and in clinical trial registries rather than being reported in the published medical journal reports of the studies.


View the original article here

Saturday, May 4, 2013

Vision Loss, Depression May Be Linked, Study Finds

Title: Vision Loss, Depression May Be Linked, Study Finds
Category: Health News
Created: 3/7/2013 4:36:00 PM
Last Editorial Review: 3/8/2013 12:00:00 AM

View the original article here

Shared Genes May Link ADHD, Autism and Depression

Largest study of its kind also found ties to

By Steven Reinberg

HealthDay Reporter

WEDNESDAY, Feb. 27 (HealthDay News) -- Autism, attention-deficit/hyperactivity disorder (ADHD), major depression, bipolar disorder and schizophrenia may all share common genetic risk factors, a new study says.

In this largest study of its kind, researchers spotted gene variations governing brain function that may raise the risk for these often devastating mental woes. In the future, these gene variants might become key targets for prevention or treatment, the scientists said.

"This study, for the first time, shows that there are specific genetic variants that influence a range of childhood and adult-onset psychiatric disorders that we think of as clinically different," said lead researcher Dr. Jordan Smoller, a professor of psychiatry at Harvard Medical School in Boston.

"We also found that there was significant overlap in the genetic components of several disorders, especially schizophrenia with bipolar disorder and depression, and to a lesser extent autism with schizophrenia and bipolar disorder," he said.

The researchers don't yet understand exactly how these variants are involved in the disorders, he noted. "This is the first clue that specific genes and pathways may cause a broader susceptibility to a number of disorders. Now the important work will be to figure out how this actually happens," said Smoller, who is also associate vice chair of the department of psychiatry at Massachusetts General Hospital.

Dr. Alessandro Serretti, from the Psychiatry Institute at the University of Bologna in Italy, wrote an accompanying journal editorial on the study. He believes that "we are now able to understand what are the pathways to [these] psychiatric disorders."

There are potential clinical applications, both in the classification of disorders, predicting who's most at risk, and perhaps new and better drug therapies, Serretti said. However, there's no immediate clinical application for these findings, he added.

The report was published Feb. 28 in the online edition of The Lancet.

To look for common genetic markers, called nucleotide polymorphisms, that might be risk factors for the five disorders, the Psychiatric Genomics Consortium scanned the genes of more than 33,000 people suffering from these disorders and nearly 28,000 people without such issues. This is the largest study of the genetics of psychiatric illness yet conducted, the researchers said.

Smoller's group found four gene areas that all overlapped with the five disorders, two of which regulate calcium balance in the brain.

These overlapping gene variants appear to increase the risk for bipolar disorder, major depressive disorder and schizophrenia in adults, the researchers said.

Further analysis found that genes governing calcium channel activity in the brain might also be important in the development of all five disorders, autism and ADHD included.

Smoller noted these genetic risk factors may only account for a very small part of the risk driving these disorders, and just how big a share they account for isn't yet known.


View the original article here

Monday, April 8, 2013

Untreated Depression May Cut Shingles Vaccine Effectiveness

Title: Untreated Depression May Cut Shingles Vaccine Effectiveness
Category: Health News
Created: 2/14/2013 10:35:00 AM
Last Editorial Review: 2/14/2013 12:00:00 AM

View the original article here

Friday, March 22, 2013

Electrical Brain Stimulation Plus Drug Fights Depression: Study

Combination of approaches appears to give the

By Steven Reinberg

HealthDay Reporter

WEDNESDAY, Feb. 6 (HealthDay News) -- Treating major depression safely and affordably is a challenge. Now, Brazilian researchers have found that two techniques often used individually produce better results when used together.

The researchers paired the antidepressant Zoloft (sertraline) and a type of noninvasive brain stimulation called transcranial direct current stimulation (tDCS) to treat people with moderate to severe symptoms of major depression.

Transcranial direct current stimulation appears to be just as effective a treatment as Zoloft, but the two together are even more effective, said lead researcher Dr. Andre Russowsky Brunoni, from the Clinical Research Center at University Hospital of the University of Sao Paulo.

This painless treatment uses a low-intensity electrical current to stimulate specific parts of the brain. Previously, it has been tested for various conditions, such as stroke, anxiety, pain and Parkinson's disease, the researchers said.

Dr. Sarah Hollingsworth Lisanby, chair of the department of psychiatry and behavioral sciences at Duke University School of Medicine, is enthusiastic about the findings.

Lisanby said the advent of technologies such as noninvasive brain stimulation is "one of the exciting new developments" in treating depression.

Transcranial direct current stimulation is one of a family of approaches that uses electrical or magnetic fields to stimulate the brain to alter brain function, she said.

"These techniques offer great promise for people with depression, because we know, unfortunately, medications aren't always effective, and psychotherapy isn't always effective, so having effective alternatives is important," Lisanby said.

She noted the current study's two-pronged approach addresses both aspects of brain action. The drug affects the chemical aspects of brain function, while the electrical stimulation targets the brain's electrical activity.

"Because the brain is an electro/chemical organ, using both electrical and chemical approaches to treat it makes intuitive sense," she said.

For the report, published online Feb. 6 in JAMA Psychiatry, Brunoni's team divided 120 patients with major depression who had never taken antidepressants to take Zoloft or an inactive placebo every day with or without electrical brain stimulation, or with sham stimulation.

After six weeks of treatment, Brunoni's group found depression significantly improved among patients receiving Zoloft or electrical brain stimulation. However, the biggest gain was seen in those who received both therapies. To gauge improvement, the researchers used the Montgomery-Asberg depression rating scale.

Overall, the patients received 12 half-hour brain stimulation sessions over six weeks.

Side effects from brain stimulation usually are mild and include itching, scratching and redness on the stimulated area, Brunoni said.

However, the combination treatment was associated with more cases of mania after treatment, he said. "Although we could not rule out whether this association was spurious, other studies should investigate this issue," Brunoni said.

Brain stimulation alone could be useful for patients who can't take psychiatric drugs, he said. And the devices that deliver the treatment are relatively affordable, the authors noted.


View the original article here

Wednesday, March 20, 2013

Maternal Depression, Violence at Home May Raise Child's ADHD Risk

Study found kids who were exposed to one or both

By Denise Mann

HealthDay Reporter

THURSDAY, Feb. 7 (HealthDay News) -- Preschoolers whose parents report depression and intimate partner violence may be more likely to develop attention-deficit/hyperactivity disorder (ADHD) by the age of 6, new research suggests.

And young children with depressed moms may be more likely to receive prescription drugs to treat behavioral and mental health issues down the road.

"Our study indicates that preschoolers who are diagnosed with ADHD are more likely to have been exposed to both intimate partner violence and parental depression within the first three years of life than their peers not exposed to either risk factor," said study author Dr. Nerissa Bauer, an assistant professor of pediatrics at Indiana University School of Medicine, in Indianapolis.

"There has been increasing awareness that certain psychosocial risk factors can impact the behavioral presentation of children at very young ages," she said. Still, not all children who are exposed to maternal depression and intimate partner violence will develop ADHD, she noted.

"There are other factors that can be associated with a child's higher likelihood of being diagnosed with ADHD, including a family history of ADHD," Bauer explained.

ADHD symptoms can include impulsiveness, hyperactivity and difficulty focusing. Kids with ADHD may have difficulty in school, holding down jobs and sustaining relationships. They are also at greater risk for alcohol or substance abuse, depression and anxiety disorders. Treatment typically involves medication and behavioral modifications.

"Pediatricians and family practitioners know to routinely screen for the presence of these psychosocial risk factors because of the potential negative effects on the child," Bauer said. "Families who experience intimate partner violence will need help, not only to make sure the victims stay safe from physical harm, but there [are] also psychological effects."

The study, which appeared online Feb. 4 in the journal JAMA Pediatrics, included more than 2,400 children who were 3 years old. Parents who brought them to four different pediatric community clinics filled out questionnaires regarding their personal history of depression and domestic violence while in the pediatricians' waiting room.

Fifty-eight caregivers reported a history of intimate partner violence and depression before their child turned 3. In addition, 69 reported a history of intimate partner violence and 704 had symptoms of depression during this time frame. Close to 66 percent of the parents reported neither depression nor intimate partner violence. Children who were exposed to intimate partner violence and/or parental depression were four times more likely to be diagnosed with ADHD by the age of 6.

What's more, 2.9 percent of kids whose parents reported depression received prescription drugs to treat behavioral and mental health issues, compared with 1.6 percent of children whose parents did not report a history of depression. Medications included those that treat anxiety, depression and sleep problems.


View the original article here

Wednesday, January 23, 2013

Sweetened Drinks Linked to Depression Risk

soda cans

Jan. 8, 2013 -- Drinking sweetened beverages -- either sugar-sweetened or diet -- may be linked with a slightly higher depression risk, while drinking coffee may slightly lower the risk.

That is the finding from a new study to be presented in March at the 65th annual meeting of the American Academy of Neurology in San Diego.

In the study, people who drank sweetened beverages -- including regular and diet sodas, fruit punch, and sweetened iced tea -- had a higher risk for depression.

Researchers say the findings suggest that cutting down on sweetened drinks or replacing them entirely with non-sweetened beverages may help lower depression risk.

But an expert who reviewed the findings says it failed to convince him that drinking sweetened beverages raises depression risk.

“There is much more evidence that people who are depressed crave sweet things than there is to suggest that sweetened beverages cause depression,” says neurologist Kenneth M. Heilman, MD.

Heilman is a professor of neurology at the University of Florida College of Medicine in Gainesville.

The study included close to 264,000 people over the age of 50 enrolled in an AARP diet and health study.

When they entered the study, the participants were asked about their beverage-drinking habits as part of a detailed dietary survey. About 10 years later they were asked if they had been diagnosed with depression over the previous decade.

The analysis revealed that people who drank more than four cans or cups of diet soda a day had about a 30% higher risk of developing depression over the follow-up period than those who drank none. Those who drank regular soda had a 22% higher risk.

Coffee drinking, however, was associated with a 10% reduction in depression risk.

Drinking diet sweetened-beverages appeared to be associated with a slightly higher depression risk overall than drinking sugar-sweetened beverages.

The researchers noted that more research is needed to confirm the findings. They warn that people with depression should continue to take all medications prescribed by their doctors.

“While our findings are preliminary, and the underlying biological mechanisms are not known, they are intriguing and consistent with a small but growing body of evidence suggesting that artificially sweetened beverages may be associated with poor health outcomes,” says researcher Honglei Chen, MD, PhD, of the National Institutes of Health in Research Triangle Park, N.C.

Heilman, who is a member of the American Academy of Neurology, says the fact that carbonated and non-carbonated sweetened beverages appeared to increase depression risk, as did drinks sweetened with sugar and non-calorie sweeteners, leads him to question the findings.

He notes that there is evidence to suggest that people who are depressed or have a higher risk for depression seek out sweet foods and drinks as a way of self-soothing.

“The main point is that you can never show cause and effect in a study like this one,” he says. “By telling people to cut down on sugar-sweetened drinks you may be reducing depression risk or having no impact or having the opposite effect and making depression worse.”

The study was supported by the Intramural Research Programs of the National Institutes of Health, the National Institute of Environmental Health Sciences, and the National Cancer Institute.

These findings will be presented at a medical conference. They should be considered preliminary as they have not yet undergone the "peer review" process, in which outside experts scrutinize the data prior to publication in a medical journal.


View the original article here

Wednesday, January 9, 2013

Depression in Elderly May Predict Dementia

depressed mature man

Dec. 31, 2012 -- Depression is common among older people who go on to develop Alzheimer’s disease, leading to widespread speculation that it may be one possible cause for age-related dementias.

Now, a new study suggests that rather than being a cause of memory decline, depression in older people may be an early symptom of dementia.

When researchers evaluated 2,000 elderly New Yorkers for depression and then followed them, they found that depression accompanied memory declines but did not necessarily come first.

Having memory problems that are not severe enough to be diagnosed as dementia, but that are more pronounced than the changes associated with normal aging, is known as mild cognitive impairment. Many people with MCI develop dementia, but some do not.

The new research shows that having mild cognitive impairment along with depression doubled the risk of developing full-blown dementia.

But researcher Jose A. Luchsinger, MD, MPH, of Columbia University Medical Center, says depression appears to be a symptom that accompanies age-related memory loss, such as mild cognitive impairment, rather than a separate risk factor for it.

It also means that depression among the elderly should be recognized as a possible early warning sign of age-related memory decline.

The study was published online today in the journal Archives of Neurology.

“When depression and memory complaints occur together in the elderly it is often assumed that the memory problems are caused by the depression,” Luchsinger says. “The thinking is often that by treating the depression the memory problems will go away, but this may not be the case.”

He says older people who are depressed and have memory complaints should be evaluated for mild cognitive impairment or other early signs of dementia.

Neurologist Gayatri Devi, MD, of New York City’s Lenox Hill Hospital, says it makes sense that older people with early memory loss would be more vulnerable to depression.

“Especially in the early stages when people realize that something is not quite right but they don’t really understand what is happening, it is natural to become depressed,” she says.

Devi agrees that depression and memory loss in older patients are too often lumped together instead of being evaluated separately.

“Depression may be related to (memory) decline or it may be totally unrelated,” she says. “From a clinical perspective it is important to understand this. If a patient comes to me in her 70s or 80s with no history of depression and no clear reason for depression, such as the loss of a spouse or a child, I will certainly consider cognitive loss as a possible reason and do the appropriate tests.”


View the original article here